CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach

Background Recent studies have focused on the diagnostic and prognostic significance of CD24 and CD44 expression in human cancers. This study aimed to explore changes in CD44 and CD24 expression levels in patients with gastric cancer and to assess their prognostic values.